Share
The pharma industry briefing
The latest news, approvals and clinical trials you need to know about this month
Data:
News in Numbers
Data: News in Numbers
>80
China has more than 80 running or pending clinical trials for potential COVID-19 treatments
60%
The World Health Organization has forecast a 60% increase in global cancer cases if current trends continue
60%
4
The number of countries in the African region to license the Ebola vaccine Ervebo
$133m
AstraZeneca has pledged $133m to expand its facility in Sydney, Australia
10
Mumps cases have hit a ten-year high in England
Data: News in Numbers
>80
China has more than 80 running or pending clinical trials for potential COVID-19 treatments
60%
The World Health Organization has forecast a 60% increase in global cancer cases if current trends continue
4
The number of countries in the African region to license the Ebola vaccine Ervebo
$133m
AstraZeneca has pledged $133m to expand its facility in Sydney, Australia
10
Mumps cases have hit a ten-year high in England
Hormonal drug shortages in UK ‘harming women’, say doctors
UK doctors are calling on Health Secretary Matt Hancock to investigate shortages of hormone replacement therapy and contraceptive drugs that have been affecting ‘thousands of women’ in the UK for at least a year.
Source: Pharmaphorum
UK Introduces Post-Brexit Medicines and Devices Legislation
In the UK, a new bill which aims to improve regulation for medical devices and ensure patient safety, as well as allow hospitals to develop personalised medicines has come into effect.
Source: Medscape
Preclinical data of Gilead’s remdesivir raises hope for China trials
A study by the US National Institutes of Health (NIH) has demonstrated that Gilead’s antiviral drug, remdesivir, could prevent a type of coronavirus in monkeys.
Source: Pharmaceutical Technology
Amazon applies for UK 'Amazon Pharmacy' trademark
The e-commerce firm has applied for the trademark linked to the provision of pharmaceuticals, medical and veterinary preparations, online pharmacy retail, the delivery of prescription medications, and other services.
Source: The Pharmaceutical Journal
Approvals
Pemfexy (pemetrexed) Injection
The US FDA has approved Pemfexy (pemetrexed for injection), a branded alternative to Alimta for the treatment of nonsquamous non-small cell lung cancer and malignant pleural mesothelioma.
Source: Business Wire
Beovu®
(brolucizumab)
The European Commission has approved Novartis’ Beovu injection for the treatment of wet age-related macular degeneration.
Source: Novartis
Audenz
The US FDA has approved Seqirus’ Audenz™ (Influenza A (H5N1) Monovalent Vaccine, Adjuvanted) to protect individuals six months of age and older against influenza A (H5N1).
Source: Seqirus
Voltaren Arthritis Pain
The US FDA has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults (18 years and older).
Source: GloaxoSmithKline
Go to top
Go to top
Share this article
